NatureWise Biotech & Medicals Corporation (4732.TWO)
TWD 20.05
(0.25%)
TWD 20.05
(0.25%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 10.68 Million TWD | 113.98% |
| 2022 | 4.99 Million TWD | -60.25% |
| 2021 | 12.56 Million TWD | 228.11% |
| 2020 | 3.82 Million TWD | -68.67% |
| 2019 | 12.21 Million TWD | 324.97% |
| 2018 | 2.87 Million TWD | 868.01% |
| 2017 | 297 Thousand TWD | 10.0% |
| 2016 | 270 Thousand TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 8.43 Million TWD | 0.0% |
| 2024 Q1 | - TWD | -100.0% |
| 2023 FY | 10.68 Million TWD | 113.98% |
| 2023 Q3 | - TWD | -100.0% |
| 2023 Q4 | 10.68 Million TWD | 0.0% |
| 2023 Q2 | 5.1 Million TWD | 0.0% |
| 2023 Q1 | - TWD | -100.0% |
| 2022 FY | 4.99 Million TWD | -60.25% |
| 2022 Q4 | 4.99 Million TWD | 0.0% |
| 2022 Q2 | 6.38 Million TWD | 0.0% |
| 2021 Q2 | 7.68 Million TWD | 0.0% |
| 2021 FY | 12.56 Million TWD | 228.11% |
| 2021 Q4 | 12.56 Million TWD | 0.0% |
| 2020 Q4 | 3.82 Million TWD | 0.0% |
| 2020 FY | 3.82 Million TWD | -68.67% |
| 2020 Q2 | 9.5 Million TWD | 0.0% |
| 2019 Q4 | 12.21 Million TWD | 0.0% |
| 2019 FY | 12.21 Million TWD | 324.97% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 97.348% |
| Level Biotechnology Inc. | 13.5 Million TWD | 20.886% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 98.577% |
| GlycoNex Incorporation | 900 Thousand TWD | -1086.889% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 95.844% |
| OBI Pharma, Inc. | 501.05 Million TWD | 97.868% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 96.663% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 96.234% |
| Visgeneer Inc. | 158.6 Million TWD | 93.265% |
| Neith Corporation | 3.54 Million TWD | -201.666% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 15.289% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.459% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -812.212% |
| Enimmune corporation | 45.73 Million TWD | 76.643% |
| TaiRx, Inc. | 12.28 Million TWD | 13.056% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 81.648% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 97.271% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -81.112% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | 1.074% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 87.061% |
| RBC Bioscience Corporation | 487.36 Million TWD | 97.808% |
| NaviFUS Corp. | 32.69 Million TWD | 67.326% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -197.383% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -1885.502% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 25.69% |
| Sagittarius Life Science Corp | 13.32 Million TWD | 19.823% |
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 90.584% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -1127.816% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 18.408% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -96.686% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 60.614% |
| Lin BioScience, Inc. | 42.87 Million TWD | 75.085% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -672.379% |
| AP Biosciences Inc | 82.07 Million TWD | 86.986% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 93.864% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 98.433% |
| EirGenix Inc. | 465.16 Million TWD | 97.704% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 92.601% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 98.529% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -405.298% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -145.338% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 88.975% |
| VBI | - TWD | -Infinity% |
| BiOptic Inc. | 93.19 Million TWD | 88.538% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 97.438% |
| Sinew Pharma Inc. | 6.46 Million TWD | -65.254% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 94.554% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.633% |
| 3D Global Biotech Inc. | 10.37 Million TWD | -2.919% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 99.256% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 97.316% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | -34.011% |
| TCI GENE Inc. | 6.79 Million TWD | -57.204% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -28.42% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | -11.259% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 96.023% |
| PharmaEngine, Inc. | 14.8 Million TWD | 27.868% |
| Savior Lifetec Corporation | 270.37 Million TWD | 96.049% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 85.698% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 68.618% |
| Acepodia, Inc. | 273.81 Million TWD | 96.099% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 47.786% |